Skip to main content

Advertisement

Table 2 Disease characteristics, baseline disease activity scores and pharmacological treatment of patients in the exercise and non-exercising disease control groups

From: Moderate-intensity aerobic and resistance exercise is safe and favorably influences body composition in patients with quiescent Inflammatory Bowel Disease: a randomized controlled cross-over trial

  Exercise group (n = 13) Control group (n = 7) p-value
Condition (%)
 Ulcerative Colitis 8 (61.5%) 5 (71.4%) 0.658a
 Crohn’s Disease 5 (38.5%) 2 (28.6%)
 Age at diagnosis (years) 25 (25, 31) 26 (22, 31) 0.642
 Previous surgery for condition Yes: 1 (7.7%) Yes: 0 0.452a
Baseline Disease activity score
 Simple Colitis Index 1.5 (1, 2.75) 1 (0, 4) 0.833
 Harvey Bradshaw Index 1 (0, 1.5) 1 (0, 1) 1.00
Disease treatment
 Current steroid use None None  
 Steroid use in the last year (%) Yes: 5 (38.5%) No: 8 (61.5%) Yes: 3 (42.9%) No: 4 (57.1%) 0.848a
 Current anti-TNF treatment Yes: 2 (15.4%) No: 11 (84.6%) Yes: 1 (14.3%) No: 6 (85.7%) 0.948a
 Currently on immunomodulation Yes: 100% Yes: 100%  
 Azathioprine N = 1 N = 1  
 Mesalazine N = 11 N = 6  
 6-mercaptopurine N = 4 N = 2  
 Proton pump inhibitors N = 4 N = 4  
  1. Proportions, medians (interquartile ranges) are stated as appropriate. Mann-Whitney U and Chi-squared tests performed to compare groups. aIndicates Chi-squared test